PAVmed
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $996 | $979 | $1,010 | $1,049 |
Gross Profit | -385 | -992 | -1,320 | -1,287 |
EBITDA | 60,961 | -14,598 | -17,910 | -16,664 |
EBIT | 60,723 | -14,903 | -18,496 | -17,389 |
Net Income | 64,399 | -10,827 | -15,212 | -14,036 |
Net Change In Cash | 996 | 979 | 1,010 | 1,049 |
Free Cash Flow | -8,889 | -11,659 | -13,151 | -12,057 |
Cash | 765 | 25,499 | 25,536 | 19,639 |
Basic Shares | 44,475 | 9,152 | 8,694 | 8,022 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,452 | $377 | $500 | $0 |
Gross Profit | -3,968 | -3,237 | -85 | -23 |
EBITDA | -75,742 | -99,412 | -55,900 | -35,812 |
EBIT | -78,674 | -101,966 | -56,126 | -35,835 |
Net Income | -64,175 | -101,294 | -50,347 | -34,329 |
Net Change In Cash | 2,452 | 377 | 500 | 0 |
Cost of Revenue | 60,002 | 11,037 | ||
Free Cash Flow | -52,278 | -72,525 | -42,060 | -21,969 |
Cash | 19,639 | 39,744 | 77,258 | 17,256 |
Basic Shares | 7,231 | 5,938 | 5,167 | 3,162 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.54 |
2024-06-30 | -$1.19 |
2024-03-31 | -$2.62 |
2023-12-31 | -$1.81 |
